Company overview
Basic information
Company name
Lietuvos pacientų organizacijų atstovų taryba
Company code
195756130
Registered address
Vilnius, Gedimino pr. 28, LT-01104
Registration date
2002-10-28
Company age: 24 y.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
https://www.pacientutaryba.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Association
NACE activity
Activities of professional membership organisations
Sector
Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form
Private without foreign capital
Beneficiary of support
Yes, since 2004-07-02
NVO
Non-governmental organization since 2021-05-17
Lietuvos pacientų organizacijų atstovų taryba
Company code: 195756130
Address: Vilnius, Gedimino pr. 28, LT-01104
Download a detailed company report
Make confident decisions with all the information about Lietuvos pacientų organizacijų atstovų taryba. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Lietuvos pacientu organizaciju atstovu taryba (company code 195756130) is an operational association registered on 28 October 2002 and based in Vilnius, at Gedimino pr. 28-404, Vilniaus m. sav., Vilniaus apskr. It is classified as a public entity in the sector of non-profit institutions providing services to households, and its governance is described as CEO with board/council. The company operates under EVRK code T.94.12.00, Activities of professional membership organisations. It is grouped as micro sized and is described under private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. Financially, the organisation reported revenue of EUR 4.0K in 2025, up 28.8% year on year from EUR 3.1K in 2024, though still below EUR 5.5K in 2023. Net profit was EUR 927 in 2025, compared with EUR 981 in 2024 and EUR 591 in 2023, with a 23.3% profit margin in the latest financial year.